thymoquinone has been researched along with Depression in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, FJ; Akhtar, M; Alam, M; Imam, SS; Javed, MN; Najmi, AK | 1 |
| Farooq, RK; Hanif, R; Javed, A; Nasir, S; Nazir, S | 1 |
| Ahmad, FJ; Akhtar, M; Alam, M; Imam, SS; Najmi, AK; Zameer, S | 1 |
| Abd Rabo, AA; Abd-El Daim, TM; Elfeky, AS; Fahmy, HM; Khadrawy, YA; Mostafa, IT; Mustafa, AB | 1 |
| Alam, MF; Anwer, T; Khan, G; Masmali, AUM; Qumayri, HM; Safhi, MM; Siddiqui, R | 1 |
| Akhtar, M; Aquib, M; Najmi, AK | 1 |
| Aston, J; Colletto, B; Elliott, JM; Etheve, S; Fowler, A; Goralczyk, R; Kilpert, C; Mechan, AO; Mohajeri, MH; Rieger, H; Schüler, G; Seifert, N; Wöhrle, T; Wyss, A | 1 |
7 other study(ies) available for thymoquinone and Depression
| Article | Year |
|---|---|
Thymoquinone Lipid Nanoparticles Cut the Gordian Knots of Depression via Neuroprotective BDNF and Downregulation of Neuro-inflammatory NF-κB, IL-6, and TNF-α in LPS Treated Rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Benzoquinones; Biological Availability; Brain-Derived Neurotrophic Factor; Depression; Drug Delivery Systems; Liposomes; Molecular Docking Simulation; Nanoparticles; Neuroimmunomodulation; Neurons; Neuroprotection; NF-kappa B; Plant Preparations; Rats; Signal Transduction; Tumor Necrosis Factor-alpha | 2021 |
Therapeutic effect of Thymoquinone on behavioural response to UCMS and neuroinflammation in hippocampus and amygdala in BALB/c mice model.
Topics: Amygdala; Animals; Benzoquinones; Depression; Depressive Disorder, Major; Disease Models, Animal; Hippocampus; Mice; Mice, Inbred BALB C; Neuroinflammatory Diseases; Stress, Psychological | 2022 |
Thymoquinone Loaded Solid Lipid Nanoparticles Demonstrated Antidepressant-Like Activity in Rats via Indoleamine 2, 3- Dioxygenase Pathway.
Topics: Animals; Antidepressive Agents; Behavior Observation Techniques; Behavior, Animal; Benzoquinones; Depression; Disease Models, Animal; Drug Carriers; Hippocampus; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Lipids; Male; Nanoparticles; Nigella sativa; Rats; Serotonin; Signal Transduction; Tryptophan | 2020 |
Thymoquinone-encapsulated chitosan nanoparticles coated with polysorbate 80 as a novel treatment agent in a reserpine-induced depression animal model.
Topics: Animals; Benzoquinones; Chitosan; Depression; Disease Models, Animal; Nanoparticles; Polysorbates; Rats; Reserpine | 2020 |
Thymoquinone and fluoxetine alleviate depression via attenuating oxidative damage and inflammatory markers in type-2 diabetic rats.
Topics: Animals; Antioxidants; Behavior, Animal; Benzoquinones; Biomarkers; Cytokines; Depression; Diabetes Mellitus, Experimental; Drug Interactions; Fluoxetine; Frontal Lobe; Glutathione; Inflammation; Male; Oxidative Stress; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2019 |
Antidepressant Effect of Thymoquinone in Animal Models of Depression.
Topics: Animals; Antidepressive Agents; Antioxidants; Behavior, Animal; Benzoquinones; Brain; Depression; Disease Models, Animal; Drug Synergism; Fluoxetine; Glutathione; Male; Mice; Serotonin; Thiobarbituric Acid Reactive Substances | 2015 |
Monoamine reuptake inhibition and mood-enhancing potential of a specified oregano extract.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; Benzoquinones; Biogenic Monoamines; Brain; Cymenes; Depression; Dietary Supplements; Drug Discovery; HEK293 Cells; Humans; Male; Mice; Monoamine Oxidase Inhibitors; Monoterpenes; Neurotransmitter Uptake Inhibitors; Origanum; Plant Extracts; Plant Leaves; Random Allocation; Rats; Serotonin Plasma Membrane Transport Proteins | 2011 |